Cargando…
The Ethics of Using Off-Label Medications to Treat COVID-19
Autor principal: | Huffman, Alan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mosby
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098306/ http://dx.doi.org/10.1016/j.annemergmed.2022.04.007 |
Ejemplares similares
-
COVID-19 Surges Then Crickets and the Impact on the Emergency Department Workforce
por: Huffman, Alan
Publicado: (2022) -
Ethical use of off-label disease-modifying therapies for multiple sclerosis
por: Laurson-Doube, Joanna, et al.
Publicado: (2021) -
COVID-19 and off label use of drugs: an ethical viewpoint
por: Shojaei, Amirahmad, et al.
Publicado: (2020) -
Off-Label Use vs Off-Label Marketing of Drugs: Part 1: Off-Label Use—Patient Harms and Prescriber Responsibilities
por: Van Norman, Gail A.
Publicado: (2023) -
Socio-ethical Dimension of COVID-19 Prevention Mechanism—The Triumph of Care Ethics
por: Dine, Charles Biradzem
Publicado: (2020)